Stronger memories can help us make sense of future changes
Jeffrey Zacks’s latest research turns on its head some popular beliefs about memory, showing that a failed prediction isn’t simply a failure, but also a cue which can help people update their understanding — as long as they realize their prediction was wrong.
COVID-19 cases could nearly double before Biden takes office
The number of confirmed COVID-19 cases are likely to increase to 20 million by the end of January, nearly doubling the current level of 11.4 million cases, predicts a Washington University in St. Louis COVID-19 forecasting model.
Innovative training program boosts expertise in putting cancer research into practice
Washington University’s Mentored Training for Dissemination and Implementation Research in Cancer program, the first of its kind in cancer prevention and control, has resulted in an uptick in skills, grants, publications, networking and even some practice changes.
Young people with disabilities focus of COVID-19 testing grant
School of Medicine researchers have received a grant allowing them to offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers and staff in the six special education schools operated by the Special School District of St. Louis County.
Lethal brain infections in mice thwarted by decoy molecule
School of Medicine scientists have identified a molecule that protects mice from brain infections caused by Venezuelan equine encephalitis virus, a mosquito-borne virus notorious for causing fast-spreading, deadly outbreaks in Mexico, Central America and northern South America.
Study: Respiratory failure in COVID-19 usually not driven by cytokine storm
A study led by School of Medicine researchers showed that, contrary to expectations, most people with severe COVID-19 do not suffer from unbridled inflammation. The findings suggest that anti-inflammatory therapies may not be helpful for most COVID-19 patients.
Fluvoxamine may prevent serious illness in COVID-19 patients
Researchers at Washington University School of Medicine have found that the drug fluvoxamine may help prevent deterioration in COVID-19 patients, making hospitalization less likely.
Sustainable sanitation
Alumnus Ani Vallabhaneni is co-founder of Sanergy, an organization employing systems-based solutions to solve urban sanitation challenges — and transforming lives in the process.
For all ages
What would a truly intergenerational community look like? Three WashU scholars explain how a community can become more accessible for people of every age.
Making cancer cells more susceptible to dying
Cancer cells can survive even after being hit with high doses of chemotherapy or radiation, but a School of Medicine team working to make treatment more effective is focusing on ways to tweak the inner machinery of cancer cells to make them more susceptible to dying.
Older Stories